Cerebrovascular disease: Pioglitazone reduces risk of stroke or MI

Nature Reviews Cardiology 13, 182 (2016). doi:10.1038/nrcardio.2016.34 Author: Karina Huynh Insulin resistance is present in >50% of patients without diabetes who have had an ischaemic stroke or a transient ischaemic attack (TIA). The IRIS trial investigators hypothesized that pioglitazone, an insulin-sensitizing agent, could reduce rates of stroke and myocardial infarction (MI) after ischaemic stroke or

http://feeds.nature.com/~r/nrcardio/rss/current/~3/ANM5JYkNI9E/nrcardio.2016.34

Source: Nature Reviews Cardiology - March 3, 2016 Category: Cardiology Authors: Karina Huynh Tags: Research Highlight Source Type: research